Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

We blasted through our expectations for our virtual town hall on compounding semaglutide on June 26, with almost 700 people registered.

We explained not only how some drug makers are trying to muddy the waters about legit (and legal) pharmacy compounding of GLP-1s, but what APC has been doing to correct these “alternative facts” in the media. (Reporters are getting better — see “Short Takes” below.)

That kind of misinformation is a problem not just for pharmacies compounding semaglutide, but for all compounding pharmacies, because it tarnishes the entire profession’s reputation. That’s why we’re being proactive with the media, and why we’re sharing best practices for marketing if you’re compounding any GLP-1s. 

Didn’t have a chance to attend? No worries — we’ve got you covered: Click here to watch the town hall from the comfort of your favorite hotspot.